These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. Jacobson MA, Crowe S, Levy J, Aweeka F, Gambertoglio J, McManus N, Mills J. J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921 [No Abstract] [Full Text] [Related]
6. Ondansetron to prevent vomiting after cancer chemotherapy. Med Lett Drugs Ther; 1991 Jun 28; 33(847):63-4. PubMed ID: 1828531 [No Abstract] [Full Text] [Related]
7. Progress in the development of antiviral therapy for HTLV-III-associated diseases. Yarchoan R, Broder S. Important Adv Oncol; 1987 Jun 28; ():293-311. PubMed ID: 2841232 [No Abstract] [Full Text] [Related]
11. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir. Al-Samarai A, Kinghorn G, Potter C. Chemioterapia; 1987 Jun 28; 6(2 Suppl):665-6. PubMed ID: 2855616 [No Abstract] [Full Text] [Related]
12. Foscarnet effective in acyclovir-resistant herpes. Am Pharm; 1991 Nov 28; NS31(11):12. PubMed ID: 1836936 [No Abstract] [Full Text] [Related]
14. AIDS: the virus, antivirals and vaccines. Weber J. Br J Hosp Med; 1987 Feb 28; 37(2):135-7, 140-1. PubMed ID: 2950962 [Abstract] [Full Text] [Related]
15. [Chemotherapy and immunoprophylaxis of HIV infection]. Vogt M, Schooley RT, Hirsch MS. Schweiz Rundsch Med Prax; 1986 Nov 25; 75(48):1471-5. PubMed ID: 2432642 [No Abstract] [Full Text] [Related]
16. [Treatment of cytomegalovirus infections in immunosuppressed patients]. Michon C, Girard PM, Ngovan P, Simonpoli AM, Le Hoang P. Ann Med Interne (Paris); 1988 Nov 25; 139(7):511-5. PubMed ID: 2854380 [No Abstract] [Full Text] [Related]
17. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease. Matthews SJ, Cersosimo RJ, Spivack ML. Pharmacotherapy; 1991 Nov 25; 11(6):419-48; discussion 448-9. PubMed ID: 1722897 [Abstract] [Full Text] [Related]
19. [Use of ondansetron, a 5-HT3 receptor antagonist, as a new type of antiemetic in pediatric oncology]. Csáki C, Ferencz T, Koós R, Schuler D, Borsi J. Orv Hetil; 1993 Jun 20; 134(25):1363-7. PubMed ID: 8332356 [Abstract] [Full Text] [Related]
20. Treatment of CMV retinitis. Cox SW, Wahren B. N Engl J Med; 1992 Jun 18; 326(25):1701-2; author reply 1702-3. PubMed ID: 1534145 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]